Raising funding for blood cancer and GvHD research

test logo

2017 GvHD Sponsors

 Supported by




Case Comprehensive Cancer CenterCase Comprehensive Cancer Center


The Case Comprehensive Cancer Center (Case CCC) based at Case Western Reserve University (CWRU) is a partnership organization supporting all cancer related research efforts at CWRU, University Hospitals Case Medical Center, and the Cleveland Clinic. Located in Cleveland, Ohio, the Case CCC serves the cancer research and clinical needs of an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio


University Hospitals Seidman Cancer Center

University Hospitals Seidman Cancer Center, part of the Case Comprehensive Cancer Center, is dedicated to innovative treatment and promising research in the fight against cancer through ongoing studies aimed at cancer treatment and prevention.

One of only 41 Comprehensive Cancer Centers in the country designated by the National Cancer Institute (NCI), Seidman can offer cutting-edge treatments earlier than most other cancer centers. Our affiliation with Case Western Reserve University provides ongoing studies aimed at cancer treatment and prevention.

Patients receive skilled care through our multidisciplinary team approach . Experts in surgery, medical oncology, radiation therapy, pathology, nursing, social work and psychology work together to create a personalized treatment plan that meets physical, emotional and spiritual needs.

Recognized by U.S. News and World Report as one of the top hospitals for cancer care in the country, the mission of Seidman Cancer Center is simple: to cure cancer


Cleveland Clinic LogoCleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute provides world-class care to patients with cancer and is at the forefront of new and emerging clinical, translational and basic cancer research.

Cleveland Clinic is moving toward the forefront of the cancer drug discovery revolution and cancer research. Through cancer research, we have identified new molecules with anti-tumor effects, developed collaborative ties with biotechnology companies, begun training more young scientists, and expanded our base of financial support. These bold steps in cancer research will result in discovery and application of new therapies to help us eliminate cancer as a significant cause of mortality.



Grants Provided by
  • Incyte Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
Exhibits Provided by
  • AbbVie
  • Amgen
  • Avadim Technologies, Inc.
  • Celgene Corportation
  • Jazz Pharmaceuticals
  • Pfizer, Inc.
  • Pharmacyclics LLC and Janssen Biotech, Inc.
  • Seattle Genetics
Other Support Provided by
  • Pharmacyclics LLC and Janssen Biotech, Inc.
    Acceptance of funding in support of this program does not constitute endorsement of any product or manufacturer.
Patient Resource Exhibitors
  • BMTInfoNet
  • Leukemia & Lymphoma Society
  • Meredith A. Cowden Foundation
  • National Marrow Donor Program
  • nbmtLink